newsfilter
← Latest News
Business Wire·

MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions

MoonLake To Tap Into Komodo's Technology and Real-World Data To Unlock the Full Potential of Its Next-Gen Nanobody® Therapy MoonLake Immunotherapeutics (("MoonLake", NASDAQ:MLTX), a clinical-stage biotechnology